Mar 15, 2022 / 06:00PM GMT
Steven James Valiquette - Barclays Bank PLC, Research Division - Research Analyst
All right. Great. We're going to get started with our next session here with AmerisourceBergen. I'm Steven Valiquette, the health care services analyst here at Barclays.
With us from the company, we have Steve Collis, company's CEO; and also Jim Cleary, the CFO. This will be a fireside chat. We'll dive into those questions in a few minutes here. But I think first, I'm going to turn it over to Steve just to give some comments.
Steven H. Collis - AmerisourceBergen Corporation - Chairman, President & CEO
Good afternoon, everyone. I appreciate your attendance here. I think this was right 2 years ago when we -- where we come in to Miami or not. And so that's right around when things started getting canceled. So I'm just going to make some introductory comments about AmerisourceBergen. We have had a few investors that have asked us for some more fundamental sort of discussions today. So we are a pharmaceutical services and distribution company focused on the prescription
Amerisourcebergen Corp at Barclays Global Healthcare Conference Transcript
Jan 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers